Security
Rhythm Pharmaceuticals, Inc. Common Stock · RYTM
RYTMNASDAQCommon stockCurrentCIK 1649904Updated Oct 14, 2026
Name history
RHYTHM METABOLIC, INC. · through Aug 12, 2015
RYTM price & chart
Loading TradingView…
NASDAQ:RYTM on TradingView ↗In the news
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity ↗
Recent filings
SCHEDULE 13G - filed by JPMORGAN CHASE & CO regarding RHYTHM PHARMACEUTICALS, INC.
4 filing
4 filing
144 filing
144 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 506,874,000Source | 363,572,000Source | 437,266,000Source | 372,733,000Source | 381,846,000Source | 442,316,000Source | 386,685,000Source | 258,651,000Source | 480,196,000Source | 392,273,000Source | 332,745,000Source | 382,481,000Source |
| Property, Plant and Equipment, NetUSD | 237,000Source | 801,000Source | 103,000Source | 297,000Source | 973,000Source | 1,065,000Source | 462,000Source | 1,149,000Source | 1,104,000Source | 632,000Source | 1,341,000Source | 2,197,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 52,078,000Source | 47,521,000Source | 65,614,000Source | 135,586,000Source | 161,669,000Source | 62,137,000Source | 106,095,000Source | 53,428,000Source | 54,301,000Source | 89,137,000Source | 60,081,000Source | 127,677,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 33,034,000Source | 19,306,000Source | 40,408,000Source | 26,122,000Source | 17,598,000Source | 34,192,000Source | 17,825,000Source | 14,695,000Source | 26,081,000Source | 18,512,000Source | 14,867,000Source | 6,224,000Source |
| Inventory, NetUSD | 22,107,000Source | 13,895,000Source | 30,517,000Source | 18,872,000Source | 11,994,000Source | 28,651,000Source | 19,316,000Source | 8,507,000Source | 25,753,000Source | 18,741,000Source | 8,624,000Source | 2,917,000Source |
| Assets, CurrentUSD | 494,802,000Source | 340,341,000Source | 426,563,000Source | 360,680,000Source | 357,366,000Source | 430,090,000Source | 369,288,000Source | 235,753,000Source | 466,916,000Source | 374,200,000Source | 308,268,000Source | 354,236,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 23,609,000Source | 8,750,000Source | 24,741,000Source | 24,656,000Source | 8,644,000Source | 26,622,000Source | 17,659,000Source | 11,352,000Source | 26,133,000Source | 16,382,000Source | 8,931,000Source | 11,807,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,158,000Source | 3,588,000Source | 2,817,000Source | 3,262,000Source | 3,696,000Source | 2,936,000Source | 3,367,000Source | 670,000Source | 3,049,000Source | 3,477,000Source | 781,000Source | 1,182,000Source |
| Other Assets, NoncurrentUSD | — | — | — | — | — | — | — | — | 3,286,000Source | 7,326,000Source | 14,999,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 211,191,000Source | 210,876,000Source | 219,965,000Source | 239,150,000Source | 202,351,000Source | 204,700,000Source | 223,596,000Source | 197,070,000Source | 210,170,000Source | 227,724,000Source | 162,986,000Source | 118,219,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 67,000Source | 61,000Source | 69,000Source | 64,000Source | 60,000Source | 69,000Source | 62,000Source | 60,000Source | 67,000Source | 61,000Source | 59,000Source | 56,000Source |
| Additional Paid in CapitalUSD | 1,454,048,000Source | 1,123,768,000Source | 1,560,640,000Source | 1,241,744,000Source | 1,108,269,000Source | 1,529,909,000Source | 1,223,772,000Source | 1,097,810,000Source | 1,491,675,000Source | 1,177,045,000Source | 1,064,302,000Source | 974,356,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,304,372,000Source | -1,112,010,000Source | -1,456,814,000Source | -1,251,468,000Source | -1,068,369,000Source | -1,407,516,000Source | -1,204,836,000Source | -1,036,108,000Source | -1,351,877,000Source | -1,155,338,000Source | -894,736,000Source | -710,058,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -926,000Source | -604,000Source | -912,000Source | -2,248,000Source | -617,000Source | 444,000Source | -51,000Source | -181,000Source | -796,000Source | -39,000Source | 134,000Source | -92,000Source |
| Stockholders' Equity Attributable to ParentUSD | 148,817,000Source | 11,215,000Source | 102,983,000Source | -11,908,000Source | 39,343,000Source | 122,906,000Source | 18,947,000Source | 61,581,000Source | 139,069,000Source | 21,729,000Source | 169,759,000Source | 264,262,000Source |
| Liabilities and EquityUSD | 506,874,000Source | 363,572,000Source | 437,266,000Source | 372,733,000Source | 381,846,000Source | 442,316,000Source | 386,685,000Source | 258,651,000Source | 480,196,000Source | 392,273,000Source | 332,745,000Source | 382,481,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 104,267,000Source | 97,605,000Source | 123,587,000Source | 129,455,000Source | 54,722,000Source | 103,198,000Source | 111,823,000Source | 54,160,000Source | 105,942,000Source | 115,517,000Source | 55,203,000Source | 39,809,000Source |
| Operating Lease, Liability, CurrentUSD | 624,000Source | — | 703,000Source | 510,000Source | 816,000Source | 676,000Source | 224,000Source | 793,000Source | 650,000Source | — | 770,000Source | 684,000Source |
| Accounts Payable, CurrentUSD | 13,631,000Source | 4,887,000Source | 16,165,000Source | 15,982,000Source | 4,543,000Source | 12,299,000Source | 11,912,000Source | 7,550,000Source | 13,947,000Source | 12,328,000Source | 4,885,000Source | 4,797,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,515,000Source | 4,030,000Source | 2,979,000Source | 3,681,000Source | 3,301,000Source | 3,163,000Source | 3,839,000Source | 284,000Source | 3,342,000Source | 3,938,000Source | 490,000Source | 1,260,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | 54,797,000Source | — | — | 48,077,000Source | — | 59,314,000Source | 44,531,000Source | 83,855,000Source | 62,658,000Source | 48,262,000Source | 32,894,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 416,100,000Source | 298,390,000Source | 330,900,000Source | 291,000,000Source | 319,130,000Source | 340,600,000Source | 314,488,000Source | 201,199,000Source | 388,900,000Source | 320,565,000Source | 275,846,000Source | 333,288,000Source |
| Deferred Revenue, CurrentUSD | — | 1,286,000Source | 0Source | — | 1,286,000Source | 48,000Source | 1,300,000Source | 1,286,000Source | 194,000Source | 1,286,000Source | 1,286,000Source | 1,434,000Source |
| Deferred Revenue, NoncurrentUSD | — | 109,241,000Source | — | — | 108,372,000Source | — | — | 107,368,000Source | — | — | 106,143,000Source | 75,810,000Source |
| Long-term Debt, Current MaturitiesUSD | 5,556,000Source | — | 12,703,000Source | 3,778,000Source | — | 10,130,000Source | 1,590,000Source | — | 7,296,000Source | 1,541,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 103,409,000Source | — | 93,399,000Source | 106,014,000Source | — | 98,339,000Source | 107,934,000Source | — | 100,886,000Source | 108,269,000Source | — | — |
| Short-term InvestmentsUSD | 363,974,000Source | 250,869,000Source | 265,283,000Source | 155,444,000Source | 157,461,000Source | 278,488,000Source | 208,393,000Source | 147,771,000Source | 334,648,000Source | 231,428,000Source | 215,765,000Source | 205,611,000Source |
| Preferred Stock, Value, Issued | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Other Liabilities, Noncurrent | — | — | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -55,639,000Source | -49,498,000Source | -196,539,000Source | -260,602,000Source | -184,678,000Source | -181,119,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | — | 500,000Source | 710,000Source | 903,000Source | 896,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 23,099,000Source | 12,862,000Source | 66,818,000Source | 39,682,000Source | 32,553,000Source | 19,831,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 8,110,000Source | -687,000Source | 7,570,000Source | 3,645,000Source | 8,643,000Source | 5,199,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 3,086,000Source | 575,000Source | 7,474,000Source | 10,117,000Source | 5,707,000Source | 2,806,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -44,185,000Source | -40,351,000Source | -115,675,000Source | -113,879,000Source | -136,157,000Source | -173,428,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 57,052,000Source | 24,812,000Source | -137,153,000Source | -48,173,000Source | -5,665,000Source | 28,029,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 953,000Source | — | 47,000Source | 281,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -5,400,000Source | 32,499,000Source | 217,963,000Source | 191,242,000Source | 74,368,000Source | 213,828,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | 4,288,000Source | 4,615,000Source | 19,917,000Source | 12,900,000Source | 7,398,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 7,915,000Source | 16,958,000Source | -34,778,000Source | 29,192,000Source | -67,596,000Source | 68,429,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 66,818,000Source | 39,682,000Source | 32,553,000Source | 19,831,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | 855,000Source | 774,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 416,100,000Source | 298,390,000Source | 330,900,000Source | 291,000,000Source | 340,600,000Source | 314,488,000Source | 388,900,000Source | 320,565,000Source | 275,846,000Source | 333,288,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | — | — | 0Source | 8,900,000Source | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | — | — | — | — | — | — | — | — | — | -1,040,000Source |
| Income Tax Expense (Benefit)USD | — | — | 111,000Source | -344,000Source | 444,000Source | 337,000Source | 545,000Source | 80,000Source | 497,000Source | 346,000Source | 564,000Source | — |
| InterestExpenseNonoperatingUSD | — | — | 4,742,000Source | 5,242,000Source | 4,540,000Source | 5,817,000Source | 4,583,000Source | 5,409,000Source | 20,583,000Source | 20,603,000Source | — | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | 488,000Source | — | — | — | — | -10,000Source | — | — | 366,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -52,904,000Source | -43,641,000Source | -49,298,000Source | -46,632,000Source | -55,639,000Source | -49,498,000Source | -196,539,000Source | -260,602,000Source | -184,678,000Source | -181,119,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -54,279,000Source | -44,970,000Source | -50,363,000Source | -47,981,000Source | -56,743,000Source | -50,820,000Source | -201,917,000Source | -264,572,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | -140,000Source | -100,000Source | -302,000Source | -999,000Source | -2,733,000Source | -2,414,000Source | -4,026,000Source | 5,247,000Source | 243,000Source | -1,962,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 302,000Source | — | — | — | — | — | — | 551,000Source | 551,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 274,000Source | 1,088,000Source | 1,018,000Source | 1,576,000Source | -1,704,000Source | -644,000Source | 1,264,000Source | 2,239,000Source | 190,000Source | -790,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 34,034,000Source | 34,035,000Source | 39,146,000Source | 48,875,000Source | 131,112,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | 0Source | — | 24,370,000Source | 72,338,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 6,095,000Source | 2,226,000Source | 13,604,000Source | 15,976,000Source | 7,468,000Source | 9,752,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 77,428,000Source | 23,638,000Source |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Debt and Equity Securities, Gain (Loss) | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 51,298,000Source | 33,251,000Source | 71,255,000Source | 48,502,000Source | 60,112,000Source | 32,704,000Source | 189,757,000Source | 130,126,000Source | 77,428,000Source | — |
| Cost of RevenueUSD | — | — | 5,499,000Source | 3,828,000Source | 8,931,000Source | 5,543,000Source | 7,157,000Source | 3,648,000Source | 19,492,000Source | 13,368,000Source | 9,302,000Source | 2,133,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 52,425,000Source | 35,377,000Source | 67,448,000Source | 45,947,000Source | 63,591,000Source | 39,087,000Source | 194,941,000Source | 144,304,000Source | 117,532,000Source | 92,032,000Source |
| Operating Income (Loss)USD | — | — | -52,653,000Source | -43,885,000Source | -48,552,000Source | -45,296,000Source | -52,361,000Source | -47,004,000Source | -192,016,000Source | -265,503,000Source | -184,357,000Source | -179,157,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 274,000Source | 1,088,000Source | 1,018,000Source | 1,576,000Source | -1,704,000Source | -644,000Source | 1,264,000Source | 2,239,000Source | 190,000Source | -790,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -52,793,000Source | -43,985,000Source | -48,854,000Source | -46,295,000Source | -55,094,000Source | -49,418,000Source | -196,042,000Source | -260,256,000Source | -184,114,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 111,000Source | -344,000Source | 444,000Source | 337,000Source | 545,000Source | 80,000Source | 497,000Source | 346,000Source | 564,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -52,904,000Source | -43,641,000Source | -49,298,000Source | -46,632,000Source | -55,639,000Source | -49,498,000Source | -196,539,000Source | -260,602,000Source | -184,678,000Source | -181,119,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.82Source | -0.73Source | -0.73Source | -0.75Source | -0.83Source | -0.81Source | -3.11Source | -4.34Source | -3.2Source | -3.47Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.82Source | -0.73Source | -0.73Source | -0.75Source | -0.83Source | -0.81Source | -3.11Source | -4.34Source | -3.2Source | -3.47Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 66,261,055Source | 61,219,918Source | 68,592,661Source | 63,684,359Source | 67,974,193Source | 63,059,165Source | 64,984,361Source | 60,995,204Source | 57,673,128Source | 52,120,701Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 66,261,055Source | 61,219,918Source | 68,592,661Source | 63,684,359Source | 67,974,193Source | 63,059,165Source | 64,984,361Source | 60,995,204Source | 57,673,128Source | 52,120,701Source |
| Interest Expense (non-operating)USD | — | — | 4,742,000Source | 5,242,000Source | 4,540,000Source | 5,817,000Source | 4,583,000Source | 5,409,000Source | 20,583,000Source | 20,603,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | 855,000Source | 774,000Source |
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 62,000Source |
| Costs and ExpensesUSD | — | — | 103,951,000Source | 77,136,000Source | 119,807,000Source | 93,798,000Source | 112,473,000Source | 79,708,000Source | 381,773,000Source | 395,629,000Source | 261,785,000Source | 202,795,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 497,000Source | 346,000Source | 564,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -196,054,000Source | -258,927,000Source | -178,669,000Source | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 13,892,000Source | 5,201,000Source |
| Investment Income, NetUSD | — | — | 4,328,000Source | 4,054,000Source | 3,220,000Source | 3,242,000Source | 3,554,000Source | 3,639,000Source | 15,293,000Source | 14,711,000Source | 13,945,000Source | 4,029,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -54,279,000Source | -44,970,000Source | -50,363,000Source | -47,981,000Source | -56,743,000Source | -50,820,000Source | -201,917,000Source | -264,572,000Source | — | — |
| Nonoperating Income (Expense)USD | — | — | -140,000Source | -100,000Source | -302,000Source | -999,000Source | -2,733,000Source | -2,414,000Source | -4,026,000Source | 5,247,000Source | 243,000Source | -1,962,000Source |
| Operating Lease, ExpenseUSD | — | — | — | 302,000Source | — | — | — | — | — | — | 551,000Source | 551,000Source |
| Research and Development ExpenseUSD | — | — | 46,027,000Source | 37,931,000Source | 43,428,000Source | 42,308,000Source | 41,725,000Source | 36,973,000Source | 167,340,000Source | 237,957,000Source | 134,951,000Source | 108,630,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 77,428,000Source | 23,638,000Source |
| Debt and Equity Securities, Gain (Loss) | — | — | — | —Source | — | — | — | — | — | — | — | — |
Filing attachments
tm263259d1_ex99-1.htm · S-8 · 2026-01-16
Exhibit 99.1 Rhythm Pharmaceuticals, Inc. Deferred Compensation Plan (Employees) Effective Date January 15, 2026 Rhythm Pharmaceuticals, Inc. Deferred Compensation Plan (Employees) Table of Contents Article I ──────────────────────────────────────────────────────────────────────── Establishment and Purpose 1 Article II Definitions 1 Article III Eligibility and Par…
Read attachment ↗